Department of Medicine

Shown here are members of the team working to evaluate new drug candidates for the treatment of kidney diseases.
October 6, 2022

Kidney diseases research collaboration renewed

Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.

By Nancy Humphrey
October 4, 2022

Vanderbilt’s Terker wins NIH Director’s Early Independence Award

Andrew Terker, MD, PhD, a physician-scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award.

By Bill Snyder
September 30, 2022

VUMC in the news, Oct. 4, 2022

September 29, 2022

Suzie Brown, singer-songwriter, meet Dr. Suzanne Brown Sacks, transplant cardiologist

Her twin passions for music and for medicine brought her to Nashville and to VUMC

By Matt Batcheldor
September 29, 2022

New Clinician Spotlight: Muhamed Baljević

Specializing in myeloma, amyloidosis and other plasma cell disorders, hematologist and medical oncologist Muhamed Baljević, MD, recently joined Vanderbilt University Medical Center.

By VUMC News and Communications
September 29, 2022

Penicillin delabeling initiative expanding to more patient care areas

Efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center.

By Paul Govern
September 29, 2022

Policy, resources crucial for lung cancer screening: study

Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.
By Leigh MacMillan
September 29, 2022

Study shows CMS reimbursement not associated with wider EPD use

Vanderbilt research shows that higher reimbursement from the Centers for Medicare & Medicaid Services was not associated with wider use of an embolic protection device during transcatheter aortic valve replacement procedures.
By Matt Batcheldor
September 28, 2022

October Medicine Grand Rounds announced

By VUMC News and Communications
September 27, 2022

Diagnostic biomarker for bone disorder

A urine chemical performs better as a diagnostic biomarker for the soft bone disease hypophosphatasia than other laboratory measures, Vanderbilt researchers have demonstrated.
By Leigh MacMillan
September 22, 2022

Self named co-principal investigator of Vanderbilt’s Clinical and Translational Science Award

Wesley Self, MD, MPH, a physician-scientist at Vanderbilt University Medical Center, has been named co-principal investigator (co-PI) of Vanderbilt’s Clinical and Translational Science Award (CTSA).  
By Bill Snyder
September 22, 2022

Reduced exercise capacity in ICU survivors

ICU survivors who have impaired exercise capacity months after discharge may have damaged muscle mitochondria — the energy powerhouses of the cell, Vanderbilt researchers propose.
By Kelsey Pinckard
September 15, 2022

Study suggests new mechanism for lipid transporter

A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.
By Leigh MacMillan
1 … 38 39 40 41 42 … 124